| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.01B | 5.78B | 5.66B | 6.01B | 8.40B | 8.28B |
| Gross Profit | 4.74B | 4.53B | 4.52B | 4.97B | 7.13B | 7.05B |
| EBITDA | 1.54B | 1.35B | 1.39B | 1.37B | 3.74B | 4.29B |
| Net Income | 837.81M | 698.94M | 762.99M | 671.95M | 2.43B | 2.80B |
Balance Sheet | ||||||
| Total Assets | 7.50B | 6.91B | 6.67B | 7.38B | 9.04B | 8.41B |
| Cash, Cash Equivalents and Short-Term Investments | 4.80B | 4.19B | 4.13B | 4.08B | 5.80B | 5.42B |
| Total Debt | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M |
| Total Liabilities | 1.46B | 1.29B | 1.30B | 1.30B | 1.63B | 1.76B |
| Stockholders Equity | 6.05B | 5.61B | 5.37B | 6.08B | 7.42B | 6.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 763.11M | 1.52B | 260.71M | 2.12B | 2.08B |
| Operating Cash Flow | 0.00 | 773.14M | 1.83B | 618.54M | 2.60B | 2.40B |
| Investing Cash Flow | 0.00 | -271.66M | -295.02M | -336.96M | -537.22M | -366.63M |
| Financing Cash Flow | 0.00 | -444.12M | -1.47B | -2.01B | -1.69B | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥12.58B | 14.72 | ― | 2.91% | 10.68% | 59.15% | |
72 Outperform | ¥24.40B | 16.33 | ― | 3.50% | 12.08% | 16.50% | |
71 Outperform | ¥22.42B | 8.70 | ― | 2.18% | ― | ― | |
64 Neutral | ¥30.71B | 31.60 | ― | 4.39% | 7.87% | -23.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥10.71B | 13.18 | ― | ― | 11.62% | ― | |
52 Neutral | ¥1.78B | 23.80 | ― | ― | 19.02% | 15.39% |